WuXi Financial Statements From 2010 to 2024
| WXIBF Stock | USD 1.63 0.05 2.98% |
Check WuXi Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among WuXi main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . WuXi financial statements analysis is a perfect complement when working with WuXi Biologics Valuation or Volatility modules.
WuXi |
WuXi Biologics Company Shares Outstanding Analysis
WuXi Biologics' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current WuXi Biologics Shares Outstanding | 4.22 B |
Most of WuXi Biologics' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WuXi Biologics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, WuXi Biologics has 4.22 B of shares currently outstending. This is much higher than that of the Healthcare sector and significantly higher than that of the Biotechnology industry. The shares outstanding for all United States stocks is significantly lower than that of the firm.
WuXi Biologics Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining WuXi Biologics's current stock value. Our valuation model uses many indicators to compare WuXi Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across WuXi Biologics competition to find correlations between indicators driving WuXi Biologics's intrinsic value. More Info.WuXi Biologics is rated first in return on equity category among related companies. It is rated first in return on asset category among related companies reporting about 0.45 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for WuXi Biologics is roughly 2.23 . Comparative valuation analysis is a catch-all model that can be used if you cannot value WuXi Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WuXi Biologics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the WuXi Biologics' earnings, one of the primary drivers of an investment's value.About WuXi Biologics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include WuXi Biologics income statement, its balance sheet, and the statement of cash flows. WuXi Biologics investors use historical funamental indicators, such as WuXi Biologics's revenue or net income, to determine how well the company is positioned to perform in the future. Although WuXi Biologics investors may use each financial statement separately, they are all related. The changes in WuXi Biologics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on WuXi Biologics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on WuXi Biologics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in WuXi Biologics. Please read more on our technical analysis and fundamental analysis pages.
WuXi Biologics Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the Peoples Republic of China, North America, Europe, and internationally. The company was incorporated in 2014 and is headquartered in Wuxi, China. Wuxi Biologics is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| MSFT | Microsoft | |
| CRM | Salesforce | |
| GOOG | Alphabet Inc Class C |
Check out the analysis of WuXi Biologics Correlation against competitors. Note that the WuXi Biologics information on this page should be used as a complementary analysis to other WuXi Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for WuXi Pink Sheet analysis
When running WuXi Biologics' price analysis, check to measure WuXi Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy WuXi Biologics is operating at the current time. Most of WuXi Biologics' value examination focuses on studying past and present price action to predict the probability of WuXi Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move WuXi Biologics' price. Additionally, you may evaluate how the addition of WuXi Biologics to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |